Core Insights - The company reported a revenue of €116.0 million for H1 2025, reflecting a 7.4% increase compared to H1 2024, with a like-for-like growth of 6.4% [6][3] - Recurring EBITDA reached €29.8 million, up 5.5% from the previous year, while the current operating profit increased by 1.2% to €21.1 million [6][3] - Net profit remained stable at €18.1 million, showing a slight increase of 0.3% [6][3] Financial Performance - Revenue breakdown shows growth across various divisions, with Pharmagest contributing €85.9 million (+4.7% like-for-like) and e-Connect showing significant growth of 36.6% to €7.5 million [7][16] - The recurring EBITDA margin slightly decreased to 25.7% from 26.1% in the previous year [4][6] - The net financial surplus increased by €19.2 million to €98.8 million, indicating a strong financial position [6][22] Division Highlights - **Pharmagest Division**: Stable current operating profit of €14.1 million, but a decrease in profit margin to 16.4% [8][9] - **Axigate Link Division**: Current operating profit remained stable at €4.4 million, with a margin decrease to 26.5% [13][15] - **e-Connect Division**: Current operating profit grew to €2.7 million, but the margin decreased to 36.0% [16][17] - **Medical Solutions Division**: Significant revenue growth of 29.1% to €5.1 million, with an improved margin of 6.7% [18][19] - **Fintech Division**: Experienced an operating loss of €0.3 million, with sales down 7.6% to €1.0 million [20] Strategic Developments - The company completed the acquisition of DIS and ResUrgences businesses, enhancing the Axigate Link Division's position in the public healthcare sector [23][24] - The estimated contribution of the acquired businesses to Group revenue is projected at 1.3% starting in Q3 2025 [25] - The company maintains its growth guidance of nearly 10% for H2 2025, driven by organic growth and contributions from recent acquisitions [26]

Company Overview - WELL Health Technologies Corp. is a digital healthcare company focused on improving health outcomes through technology, operating over 220 clinics and supporting more than 42,000 healthcare providers across Canada and the US [5][6] - WELLSTAR Technologies Corp., a majority-owned subsidiary of WELL, is a leading provider of interoperable technology solutions for healthcare providers in Canada [1][6] Upcoming Conference Participation - WELL and WELLSTAR will participate in the 2025 Cantech Investment Conference on October 9, 2025, in Toronto, Ontario [1][3] - The conference will feature presentations from WELL's CEO Hamed Shahbazi and WELLSTAR's CEO Amir Javidan, focusing on WELL's growth strategy and WELLSTAR's technological capabilities [2][3] Presentation Details - WELL's presentation is scheduled for 1:30 PM EST, while WELLSTAR's presentation will take place at 4:00 PM EST on the same day [3] - The conference is seen as an opportunity to highlight the companies' progress and build relationships with the investment community [3][4] Strategic Focus - WELL aims to reduce administrative burdens, increase provider efficiency, and improve patient care through the use of WELLSTAR and HEALWELL AI technologies [3][4] - The company emphasizes its role as the largest provider of outpatient services in Canada, showcasing its comprehensive healthcare and digital platform [5][6]